サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679415

ヌクレオチドの市場規模、シェア、動向分析レポート：製品別、技術別、用途別、地域別、セグメント予測、2025年～2030年

Nucleotide Market Size, Share & Trends Analysis Report By Product (Deoxy Nucleotides), By Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), By Application, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヌクレオチドの市場規模、シェア、動向分析レポート：製品別、技術別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年02月28日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヌクレオチド市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のヌクレオチド市場規模は2025～2030年にかけてCAGR 8.6％を記録し、2030年には15億2,000万米ドルに達する見込みです。

世界のヌクレオチド市場は、医薬品や飲食品産業で広く使用されているため、予測期間中に大幅な成長が見込まれています。診断研究と医薬品用途は、免疫力強化、腸への好影響、ストレスからの回復への好影響などの特性により、ヌクレオチド市場を独占しています。さらに、家畜栄養のための酵母由来のヌクレオチドと相まって、食物ヌクレオチドセグメントの研究開発が世界中で拡大しており、予測期間中の需要を促進すると予想されます。

ヌクレオチド市場レポートハイライト

  • TaqMan対立遺伝子識別セグメントが2024年の世界市場を独占し、次いでパイロシーケンスによるSNPが続きます。
  • 診断研究セグメントが2024年のヌクレオチド世界市場を独占。
  • デオキシヌクレオチド（dNTPs）セグメントは2024年に48.4％の収益シェアで世界のヌクレオチド市場を独占し、さらに予測期間中に最も速いCAGRで拡大する可能性が高いです。
  • 北米のヌクレオチド市場は2024年に38.9%の最大市場シェアを確保し、欧州のヌクレオチド市場は2025～2030年まで8.4%のCAGRで急拡大します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヌクレオチド市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 ヌクレオチド市場：製品ビジネス分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • デオキシヌクレオチド
  • ジデオキシヌクレオチド
  • RNA合成用ヌクレオチド（rNTP）
  • 標識ヌクレオチド

第5章 ヌクレオチド市場：技術ビジネス分析

  • 技術市場シェア、2024年と2030年
  • 技術セグメントダッシュボード
  • 市場規模と予測と動向分析、技術別、2018～2030年
  • TaqMan対立遺伝子識別
  • 遺伝子チップとマイクロアレイ
  • ピロシークエンスによるSNP
  • その他

第6章 ヌクレオチド市場：用途ビジネス分析

  • 用途市場シェア、2024年と2030年
  • 用途セグメントダッシュボード
  • 市場規模と予測と動向分析、用途別、2018～2030年
  • 医薬品
  • 診断調査
  • 飲食品添加物
  • 動物飼料添加物
  • その他

第7章 ヌクレオチド市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • CJ CheilJedang Corp.
    • Star Lake Bioscience
    • Thermo Fisher Scientific Inc.
    • MEIHUA HOLDINGS GROUP CO., LTD.
    • F. Hoffmann-La Roche Ltd.
    • Biorigin
    • DSM
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Lallemand Inc.
    • Nanjing BIoTogether Co., Ltd.
    • NuEra Nutraceuticals Inc.
    • Ohly
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Nucleotide Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 5. Global Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 6. Global Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 7. North America Nucleotide Market, By Country, 2018 - 2030 (USD Million)
  • Table 8. North America Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. North America Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 10. North America Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 11. U.S. Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 12. U.S. Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 13. U.S. Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 14. Canada Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 15. Canada Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 16. Canada Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 17. Mexico Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 18. Mexico Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 19. Mexico Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 20. Europe Nucleotide Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 22. Europe Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 23. Europe Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 24. UK Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 25. UK Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 26. UK Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 27. Germany Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 28. Germany Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 29. Germany Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 30. France Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 31. France Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 32. France Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 33. Italy Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 34. Italy Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 35. Italy Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 36. Spain Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Spain Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 38. Spain Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 39. Denmark Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 40. Denmark Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 41. Denmark Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 42. Sweden Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 43. Sweden Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 44. Sweden Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 45. Norway Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 46. Norway Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 47. Norway Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Nucleotide Market, By Country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 52. Japan Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 53. Japan Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 54. Japan Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 55. China Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 56. China Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 57. China Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 58. India Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 59. India Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 60. India Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 61. Australia Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 62. Australia Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 63. Australia Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 64. Thailand Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 65. Thailand Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 66. Thailand Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 67. South Korea Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 68. South Korea Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 69. South Korea Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 70. Latin America Nucleotide Market, By Country, 2018 - 2030 (USD Million)
  • Table 71. Latin America Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 72. Latin America Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 73. Latin America Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 74. Brazil Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 75. Brazil Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 76. Brazil Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 77. Argentina Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 78. Argentina Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 79. Argentina Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Nucleotide Market, By Country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 84. South Africa Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 85. South Africa Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 86. South Africa Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 90. UAE Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 91. UAE Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 92. UAE Nucleotide Market, By Application, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Nucleotide Market, By Product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Nucleotide Market, By Technology, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Nucleotide Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Nucleotide Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Product and Technology Outlook (USD Million)
  • Fig. 10 Application Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Nucleotide Market Dynamics
  • Fig. 13 Nucleotide Market: Porter's Five Forces Analysis
  • Fig. 14 Nucleotide Market: PESTLE Analysis
  • Fig. 15 Nucleotide Market: Product Segment Dashboard
  • Fig. 16 Nucleotide Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 17 Deoxy Nucleotides Market, 2018 - 2030 (USD Million)
  • Fig. 18 Dideoxynucleotides Market, 2018 - 2030 (USD Million)
  • Fig. 19 Nucleotides for RNA Synthesis (rNTP) Market, 2018 - 2030 (USD Million)
  • Fig. 20 Labelled Nucleotides Market, 2018 - 2030 (USD Million)
  • Fig. 21 Nucleotide Market: Technology Segment Dashboard
  • Fig. 22 Nucleotide Market: Technology Market Share Analysis, 2024 & 2030
  • Fig. 23 TaqMan Allelic Discrimination Market, 2018 - 2030 (USD Million)
  • Fig. 24 Gene Chips & Microarrays Market, 2018 - 2030 (USD Million)
  • Fig. 25 SNP by Pyrosequencing Market, 2018 - 2030 (USD Million)
  • Fig. 26 Others Market, 2018 - 2030 (USD Million)
  • Fig. 27 Nucleotide Market: Application Segment Dashboard
  • Fig. 28 Nucleotide Market: Application Market Share Analysis, 2024 & 2030
  • Fig. 29 Pharmaceuticals Market, 2018 - 2030 (USD Million)
  • Fig. 30 Diagnostics Research Market, 2018 - 2030 (USD Million)
  • Fig. 31 Food & Beverage Additive Market, 2018 - 2030 (USD Million)
  • Fig. 32 Animal Feed Additive Market, 2018 - 2030 (USD Million)
  • Fig. 33 Others Market, 2018 - 2030 (USD Million)
  • Fig. 34 Nucleotide Market Revenue, By Region
  • Fig. 35 Regional Marketplace: Key Takeaways
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 North America Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Country Dynamics
  • Fig. 39 U.S. Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Country Dynamics
  • Fig. 41 Canada Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Country Dynamics
  • Fig. 43 Mexico Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Country Dynamics
  • Fig. 46 UK Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Country Dynamics
  • Fig. 48 Germany Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 49 France Country Dynamics
  • Fig. 50 France Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy Country Dynamics
  • Fig. 52 Italy Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Country Dynamics
  • Fig. 54 Spain Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Country Dynamics
  • Fig. 56 Denmark Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden Country Dynamics
  • Fig. 58 Sweden Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 59 Norway Country Dynamics
  • Fig. 60 Norway Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 62 Japan Country Dynamics
  • Fig. 63 Japan Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 64 China Country Dynamics
  • Fig. 65 China Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 66 India Country Dynamics
  • Fig. 67 India Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 68 Australia Country Dynamics
  • Fig. 69 Australia Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand Country Dynamics
  • Fig. 71 Thailand Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea Country Dynamics
  • Fig. 73 South Korea Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil Country Dynamics
  • Fig. 76 Brazil Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina Country Dynamics
  • Fig. 78 Argentina Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 79 Middle East & Africa Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa Country Dynamics
  • Fig. 81 South Africa Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia Country Dynamics
  • Fig. 83 Saudi Arabia Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 84 UAE Country Dynamics
  • Fig. 85 UAE Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait Key Country Dynamics
  • Fig. 87 Kuwait Nucleotide Market, 2018 - 2030 (USD Million)
  • Fig. 88 Company Categorization
  • Fig. 89 Company Market Position Analysis
  • Fig. 90 Strategic Framework
目次
Product Code: 978-1-68038-627-1

Nucleotide Market Growth & Trends:

The global nucleotide market size is expected to reach USD 1.52 billion by 2030, registering a CAGR of 8.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period.

Nucleotide Market Report Highlights:

  • The TaqMan allelic discrimination segment dominated the global market in 2024, followed by SNP by pyrosequencing
  • The diagnostics research segment dominated the global market for nucleotides in 2024
  • The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2024 with a revenue share of 48.4% and is furthermore likely to expand with the fastest CAGR over the forecast period
  • North America nucleotide market secured the largest market share of 38.9% in 2024 and Europe nucleotide market is set to expand at the fastest-growing CAGR of 8.4% from 2025 to 2030

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Nucleotide Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Nucleotide Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Deoxy Nucleotides
    • 4.4.1. Deoxy Nucleotides Market, 2018 - 2030 (USD Million)
      • 4.4.1.1. Enzyme Sourced
        • 4.4.1.1.1. Enzyme Sourced Nucleotides Market, 2018 - 2030 (USD Million)
      • 4.4.1.2. Chemical Synthesis
        • 4.4.1.2.1. Chemical Synthesis Nucleotides Market, 2018 - 2030 (USD Million)
  • 4.5. Dideoxynucleotides
    • 4.5.1. Dideoxynucleotides Market, 2018 - 2030 (USD Million)
  • 4.6. Nucleotides for RNA Synthesis (rNTP)
    • 4.6.1. Nucleotides for RNA Synthesis (rNTP) Market, 2018 - 2030 (USD Million)
  • 4.7. Labelled Nucleotides
    • 4.7.1. Labelled Nucleotides Market, 2018 - 2030 (USD Million)

Chapter 5. Nucleotide Market: Technology Business Analysis

  • 5.1. Technology Market Share, 2024 & 2030
  • 5.2. Technology Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, By Technology, 2018 to 2030 (USD Million)
  • 5.4. TaqMan Allelic Discrimination
    • 5.4.1. TaqMan Allelic Discrimination Market, 2018 - 2030 (USD Million)
  • 5.5. Gene Chips & Microarrays
    • 5.5.1. Gene Chips & Microarrays Market, 2018 - 2030 (USD Million)
  • 5.6. SNP by Pyrosequencing
    • 5.6.1. Gene Chips & Microarrays Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Nucleotide Market: Application Business Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
  • 6.5. Diagnostics Research
    • 6.5.1. Diagnostics Research Market, 2018 - 2030 (USD Million)
  • 6.6. Food & Beverage Additive
    • 6.6.1. Food & Beverage Additive Market, 2018 - 2030 (USD Million)
  • 6.7. Animal Feed Additive
    • 6.7.1. Animal Feed Additive Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Nucleotide Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamic
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamic
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamic
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamic
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamic
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamic
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamic
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamic
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamic
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamic
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamic
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamic
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamic
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamic
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamic
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamic
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Thailand Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamic
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. South Korea Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamic
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamic
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamic
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamic
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamic
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamic
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Nucleotide Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. CJ CheilJedang Corp.
      • 8.5.1.1. Participant's Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Star Lake Bioscience
      • 8.5.2.1. Participant's Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Thermo Fisher Scientific Inc.
      • 8.5.3.1. Participant's Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. MEIHUA HOLDINGS GROUP CO., LTD.
      • 8.5.4.1. Participant's overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. F. Hoffmann-La Roche Ltd.
      • 8.5.5.1. Participant's Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Biorigin
      • 8.5.6.1. Participant's Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. DSM
      • 8.5.7.1. Participant's Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Promega Corporation
      • 8.5.8.1. Participant's Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Agilent Technologies, Inc.
      • 8.5.9.1. Participant's Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Lallemand Inc.
      • 8.5.10.1. Participant's Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Nanjing Biotogether Co., Ltd.
      • 8.5.11.1. Participant's Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. NuEra Nutraceuticals Inc.
      • 8.5.12.1. Participant's Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Ohly
      • 8.5.13.1. Participant's Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives